Catalyst Wire Dossier Catalyst Wire Dossier

efatutazone dihydrochloride

efatutazone
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for efatutazone dihydrochloride, covering 2019-06-27 to 2019-06-27. Get the full timeline:

Most recent: Clinical Trial Update: Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery [Phase 2]

See pricing